Cost of illness of breast cancer in Japan: trends and future projections

[1]  Hiroshi Nishimoto,et al.  Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. , 2012, Japanese journal of clinical oncology.

[2]  S. Fujita,et al.  Cost of illness of the stomach cancer in Japan - a time trend and future projections , 2013, BMC Health Services Research.

[3]  K. Katanoda,et al.  An updated report of the trends in cancer incidence and mortality in Japan. , 2013, Japanese journal of clinical oncology.

[4]  Hiroshi Nishimoto,et al.  Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. , 2013, Japanese journal of clinical oncology.

[5]  Seiichiro Yamamoto,et al.  Prevalence of breast cancer risk factors in Japan. , 2012, Japanese journal of clinical oncology.

[6]  T. Shiroiwa.  [Economic evaluation of treatment on breast cancer]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[7]  K. Katanoda,et al.  Time trends in breast cancer mortality between 1950 and 2008 in Japan, USA and Europe based on the WHO mortality database. , 2011, Japanese journal of clinical oncology.

[8]  S. Tsugane,et al.  Risk factors for breast cancer: epidemiological evidence from Japanese studies , 2011, Cancer science.

[9]  C. Yip,et al.  The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer. , 2010, Japanese journal of clinical oncology.

[10]  Rosanna Tarricone,et al.  Cost-of-illness analysis. What room in health economics? , 2006, Health policy.

[11]  Rice Dp.  Cost of illness studies: what is good about them? , 2000 .

[12]  D. Rice,et al.  Cost of illness studies: what is good about them? , 2000, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.

[13]  R. Hendrick,et al.  Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. , 1997, Journal of the National Cancer Institute. Monographs.

[14]  R E Hendrick,et al.  Benefit of mammography screening in women ages 40 to 49 Years. Current evidence from randomized controlled trials , 1995, Cancer.

[15]  A. Tamakoshi,et al.  Epidemiology of breast cancer in Japan. , 1995, International journal of epidemiology.

[16]  Karla Kerlikowske,et al.  Benefit of mammography screening in women ages 40–49 years: Current evidence from randomized controlled trials , 1995, Cancer.

[17]  Rice Dp,et al.  Cost-of-illness studies: fact or fiction? , 1994 .

[18]  DorothyP. Rice,et al.  Cost-of-illness studies: fact or fiction? , 1994, The Lancet.

[19]  Dorothy P. Rice,et al.  The economic costs of illness: A replication and update , 1985, Health care financing review.

[20]  T. Hodgson,et al.  The priceless value of human life. , 1982, American journal of public health.

[21]  T. Hodgson,et al.  The value of human life revisited. , 1982, American journal of public health.

[22]  R. Yonemoto.  Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival. , 1980, Archives of surgery.

[23]  Jay Martin.  On Japan , 1978, Current History.

[24]  C. Lowe.  An international study of breast cancer. , 1974, Proceedings of the Royal Society of Medicine.

[25]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[26]  Rice Dp,et al.  Estimating the cost of illness. , 1967 .

[27]  D. Rice,et al.  Estimating the cost of illness. , 1967, American journal of public health and the nation's health.